NCT00218686

Brief Summary

The purpose of this study is to evaluate a peer-based HIV prevention intervention that targets active injection drug users and their drug and sex partners in Chennai India.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2003

Longer than P75 for phase_2 hiv-infections

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2003

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

September 16, 2005

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 22, 2005

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
Last Updated

September 21, 2022

Status Verified

September 1, 2022

Enrollment Period

6.4 years

First QC Date

September 16, 2005

Last Update Submit

September 19, 2022

Conditions

HIV Infections

Keywords

HIVinjection drug usesocial networks

Outcome Measures

Primary Outcomes (2)

  • needle sharing

    3 month

  • condom use

    3 months

Study Arms (2)

1

EXPERIMENTAL

behavioral social network risk reduction intervention

Behavioral: psychoeducational

2

ACTIVE COMPARATOR

voluntary counseling and testing (VCT

Behavioral: control

Interventions

psychoeducationalBEHAVIORAL

psychoeducational

1
controlBEHAVIORAL

VTC

2

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • drug users
  • network members

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

YRG Care

Chennai, Tamil Nadu, 600 113, India

Location

MeSH Terms

Conditions

HIV Infections

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Carl Latkin, Ph.D.

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2005

First Posted

September 22, 2005

Study Start

January 1, 2003

Primary Completion

June 1, 2009

Study Completion

June 1, 2009

Last Updated

September 21, 2022

Record last verified: 2022-09

Locations

IN(1)